ABSCI CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.58 USD | +2.81% |
|
-3.98% | +9.05% |
| 21/03 | Earnings Flash (ABSI) ABSCI CORPORATION Reports Q4 Revenue $338,000 | MT |
| 21/03 | Absci Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Absci Corporation
20249941.51zh_yNh2JcSxoTTL7uFSMvfVdjNAmaBsgi3xYksIhY.qh-bxlow6PIrn8-de83gG5uYbIn-SAjyhmXPvb1AdESKJJTHRiao0HGOzQ~a471c57f3b9efa7bbe2471359620d6b0
Upcoming events on Absci Corporation
Past events on Absci Corporation
| 09/04/2024 12:30 am | Needham Healthcare Conference |
| 21/03/2024 05:00 pm | Q4 2023 Earnings Release |
| 19/03/2024 08:00 pm | KeyBanc Life Sciences & MedTech Forum |
| 07/03/2024 09:00 pm | H.C. Wainwright AI Based Drug Discovery & Development Conference |
| 06/03/2024 10:30 pm | KeyBanc Emerging Technology Summit |
| 05/03/2024 12:40 am | TD Cowen Health Care Conference |
| 19/01/2024 08:00 pm | Needham Growth Conference |
| 12/01/2024 12:00 am | JPMorgan Healthcare Conference |
| 29/11/2023 09:20 pm | Piper Sandler Healthcare Conference |
| 16/11/2023 07:30 pm | Canaccord Genuity MedTech Diagnostics and Digital Health and Services Forum |
| 15/11/2023 08:15 pm | Stifel Healthcare Conference |
| 15/11/2023 02:35 am | Q3 2023 Earnings Release |
| 08/11/2023 | Truist Securities Healthcare Conference - One on One |
| 04/10/2023 06:30 pm | R&D Day |
| 26/09/2023 05:40 pm | Cantor Global Healthcare Conference |
| 14/09/2023 02:25 am | Morgan Stanley Global Healthcare Conference |
| 11/09/2023 11:30 pm | H.C. Wainwright Global Investment Conference |
| 16/08/2023 02:30 am | UBS MedTech Tools and Genomics Summit - Panel |
| 14/08/2023 05:32 pm | Q2 2023 Earnings Release |
| 09/08/2023 11:30 pm | Canaccord Genuity Growth Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 4,78 5,02 -4.73% | 5,75 9,27 -38.01% | 5,72 6,40 -10.71% | 9,47 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -68,6 -67,9 -0.97% | -93,7 -97,4 3.82% | -68,8 -74,1 7.14% | -80,3 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -75,2 -68,1 -10.41% | -107 -106 -0.27% | -94,2 -101 6.29% | -92,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -110 -108 -1.72% | -105 -110 4.21% | -110 -97,4 -13.43% | -91,6 |
|
Net income Million USD | Released Forecast Spread | -14,4 | -103 -99,0 -4.3% | -105 -108 2.44% | -111 -100 -10.07% | -92,6 |
|
EPS USD | Released Forecast Spread | -10,6 | -2,08 -1,90 -9.75% | -1,15 -1,16 0.62% | -1,20 -1,19 -0.84% | -0,83 |
| Announcement Date | 06/05/21 | 22/03/22 | 30/03/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,45 1,69 -14.25% | 0,82 1,86 -55.93% | 1,00 1,68 -40.47% | 2,37 1,87 26.89% | 1,56 4,73 -67.07% | 1,27 2,03 -37.34% | 3,37 2,44 37.72% | 0,74 3,01 -75.29% | 0,34 1,03 -67.15% | 2,10 | 2,65 | 2,22 | 2,50 | 6,80 |
|
EBITDA Million USD | Released Forecast Spread | -23,5 -19,5 -20.78% | -25,9 -22,2 -16.65% | -25,7 -23,6 -9.25% | -24,6 -21,1 -16.55% | -17,5 -18,5 5.58% | -18,3 -18,9 3.02% | -15,1 -16,6 8.95% | -17,2 -16,0 -7.79% | -17,8 -19,3 7.92% | -19,6 | -18,9 | -20,2 | -21,7 | -19,0 |
|
EBIT Million USD | Released Forecast Spread | -26,3 -21,0 -25.21% | -28,8 -25,8 -11.75% | -28,9 -27,6 -4.49% | -28,0 -25,6 -9.31% | -21,1 -22,8 7.69% | -24,5 -21,6 -13.42% | -21,7 -21,6 -0.05% | -23,3 -20,0 -16.78% | -24,7 -21,6 -14.47% | -22,5 | -22,4 | -23,6 | -24,2 | -22,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,3 -25,0 -5.07% | -28,9 -29,0 0.44% | -29,0 -28,5 -1.58% | -27,6 -24,0 -14.88% | -20,0 -21,0 4.9% | -23,3 -21,4 -9.28% | -41,7 -20,8 -100.58% | -22,0 -20,7 -6.03% | -23,5 -21,9 -7.08% | -21,8 | -21,9 | -23,6 | -24,3 | -22,2 |
|
Net income Million USD | Released Forecast Spread | -25,2 -23,0 -9.34% | -29,5 -26,9 -9.5% | -28,7 -28,2 -1.59% | -27,3 -24,9 -9.56% | -19,5 -22,6 13.68% | -23,4 -22,2 -5.36% | -41,7 -22,4 -86.02% | -22,0 -21,3 -3.22% | -23,5 -22,1 -6.56% | -22,5 | -22,3 | -23,6 | -24,3 | -22,2 |
|
EPS USD | Released Forecast Spread | -0,28 -0,25 -13.45% | -0,33 -0,29 -11.94% | -0,32 -0,31 -2.78% | -0,30 -0,28 -7.08% | -0,21 -0,25 14.74% | -0,26 -0,24 -7.28% | -0,45 -0,24 -84.43% | -0,24 -0,23 -4.35% | -0,25 -0,24 -4.17% | -0,21 | -0,20 | -0,21 | -0,21 | -0,14 |
| Announcement Date | 22/03/22 | 11/05/22 | 11/08/22 | 09/11/22 | 30/03/23 | 15/05/23 | 14/08/23 | 14/11/23 | 21/03/24 | - | - | - | - | - |
More events
Past sector events for Absci Corporation
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ABSI Stock
- Calendar Absci Corporation
